top of page

International Publications [*Corresponding author(s), At PNU from [25]]

​[Year 2024]

[71] Paulraj, S., Krishnamoorthi, R., Kim, K.S., Mahalingam, P.U.* (2024) Vermiculture-based molybdenum oxide nanoparticles synthesis, optimization, characterization and its impact on seed germination and seedling characteristics in green gram (Vigna radiata). Plant Nano Biol. Accepted (April 16th, 2024).

[70] Rijia, A., Krishnamoorthi, R., Rasmi, M., Mahalingam, P.U.*, Kim, K.S.* (2024) Comprehensive analysis of bioactive compounds in wild Ganoderma applanatum mushroom from Kerala, South India: Insights into dietary nutritional, minerals, antimicrobial and antioxidant activities. Pharmaceuticals. 17(4)L 509. DOI: 0.3390/ph17040509.

 

​[Year 2023]

[69] Naskar, A., Cho, H., Kim, K.S.* (2023) Black phosphorus-based ZnO-Ag nanocomposite for antibacterial activity against tigecycline-resistant Acinetobacter baumannii. J. Compos. Sci. 7(10): 423. DOI: 10.3390/jcs7100423 

[68] Kim, J., Ahn S.B., Hong, S., Kim, K.S., Ko, E.H., Jo, I.J., Chang, J., Kim, M.H., Lee, W., Lee, H. (2023) Intracellular dynamics-resolved label-free scattering reveals real-time metabolism of single bacteria. Nano Lett. 23(7): 8225-8232. DOI: 10.1021/acs.nanolett.3c02370. 

[67] Kim, K.S.* (2023) Editorial: Global Excellence in Pharmacology of Infectious Diseases. Front. Pharmacol. 14: 1243284. DOI: 10.3389/fphar.2023.1243284

[66] Cho, H., Sondak, T., Kim, K.S.* (2023) Characterization of increased extracellular vesicle-mediated tigecycline resistance in Acinetobacter baumannii. Pharmaceutics. 15(4): 1251. DOI: 10.3390/pharmaceutics15041251.

[65] Sivastava, P., Kim, Y., Cho, H., Kim, K.S.* (2023) Synergistic action between copper oxide (CuO) nanoparticles and anthraquinone-2-carboxylic acid (AQ) against Staphylococcus aureus. J. Comps. Sci. 7(4): 135. DOI: 10.3390/jcs7040135.

[64] Naskar, A., Kim, K.S.* (2023) Friends against the foe: Synergistic photothermal and photodynamic
therapy against bacterial infections. Pharmaceutics. 15(4):1116. DOI:10.3390/pharmaceutics15041116. (Encyclopedia).

[63]  Sim, S., Lee, D.H., Kim, K.S., Park, H.J., Kim, Y.K., Choi, Y.*, Park, H.-S* (2023) Micrococcus luteus-derived extracellular vesicles attenuate neutrophilic asthma by regulating miRNAs in airway epithelial cells. Exp. Mol. Med. 55: 196-204. DOI:10.1038/s12276-022-00910-0.

[Year 2022]

[62] Srivastava P., Sondak, T., Sivashanmugam, K., Kim, K.S.* (2022) A Review of Immunomodulatory Reprogramming by Probiotics in Combating Chronic and Acute Diabetic Foot Ulcers (DFUs). Pharmaceutics. 14(11): 2436. DOI:10.3390/pharmaceutics14112436. (Encyclopedia).

[61] Srivastava P., Kim, K.S.* (2022) Membrane vesicles derived from gut microbiota and probiotics: cutting-edge therapeutic approaches for multidrug-resistant superbugs linked to neurological anomalies. Pharmaceutics. 14(11): 2370; DOI:10.3390/pharmaceutics14112370. (Encyclopedia).

[60] Naskar, A., Kim, K.S.* (2022) Photo-stimuli-responsive CuS nanomaterials as cutting-edge platform materials for antibacterial applications. Pharmaceutics. 14(11): 2343; DOI: 10.3390/pharmaceutics14112343. (Encyclopedia).

 

[59] Naskar, A.+ Cho, H.+, Kim, K.S.* (2022) A nanocomposite with extracellular vesicles from Lactobacillus paracasei as a bioinspired nanoantibiotic targeting Staphylococcus aureus. Pharmaceutics. 14(11): 2273 (+equal contribution); DOI:10.3390/pharmaceutics14112273.

[58] Naskar, A.+ Cho, H.+, Kim, K.S.* (2022) Black phosphorus-based CuS nanoplatform: Near-infrared-responsive and reactive oxygen species-generating agent against environmental bacterial pathogens. J. Env. Chem. Eng. 10(5): 108226 (+ equal contribution); DOI:10.1016/j.jece.2022.108226. 

[57] Shin, J.H., Naskar, A., Ko, D., Kim, S., Kim, K.S.* (2022) Bioconjugated Thymol-Zinc Oxide nanocomposite as a selective and biocompatible antibacterial agent against Staphylococcus species. Int. J. Mol. Sci. 23(12): 6770;  DOI:10.3390/ijms23126770

[56] Cho, H., Kim, K.S.* (2022) Repurposing of Ciclopirox to Overcome the Limitations of Zidovudine (Azidothymidine) against Multidrug-Resistant Gram-Negative Bacteria. Pharmaceutics. 14(3): 552;  DOI:10.3390/pharmaceutics14030552.

[55] Naskar, A., Shin, J., Kim, K.S.* (2022) A MoS2 based Silver-Doped ZnO nanocomposite and its antibacterial activity against β-lactamase Expressing Escherichia coli. RSC Adv. 12: 7268 - 7275; DOI:10.1039/D2RA00163B.

[54] Park, S., Park, K., Cho, H., Kwon, J., Kim, K.S., Yang, H.* (2022) Wash-Free Amperometric Escherichia coli Detection via Rapid and Specific Proteolytic Cleavage by Its Outer Membrane OmpT. Anal. Chem. 11: 4756 - 4762; DOI: 10.1021/acs.analchem.1c05299.

[53] Kim, G., Cho, H., Nandhakumar, P., Park, J.K., Kim, K.S., Yang, H.* (2022) Wash-Free, Sandwich-Type Protein Detection Using Direct Electron Transfer and Catalytic Signal Amplification of Multiple Redox Labels. Anal. Chem. 4, 2163-2171; DOI:10.1021/acs.analchem.1c04615.

[Year 2021]

[52] Naskar, A., Cho, H., Lee, S., Kim, K.S.* (2021) Biomimetic Nanoparticles Coated with Bacterial Outer Membrane Vesicles as a New Generation Platform for Biomedical Applications. Pharmaceutics. 13(11): 1887; DOI: 10.3390/pharmaceutics13111887.

[51] Naskar, A., Lee, S., Ko, D., Kim, S., Kim, K.S.* (2021) Bovine serum albumin immobilized black phosphorus based γ-Fe2O3 nanocomposite: A promising biocompatible nanoplatform. Biomedicines. 9(8): 858; DOI: 10.3390/biomedicines9080858.

[50] Cho, H., Park, K.E., Kim, K.S.* (2021) Genome analysis of Streptococcus salivarius subsp. thermophilus type strain ATCC 19258 and its comparison to equivalent strain NCTC 12958. Arch. Microbiol. 203(4): 1843-1849; DOI: 10.1007/s00203-020-02156-8.

 

[49] Cho, H., Kim, K.S.* (2021) An inducible expression system for recombinant Sca proteins with an autotransporter domain from Orientia tsutsugamushi in Escherichia coli. Prot. Pept. Lett. 28(3): 241-248; DOI: 10.2174/0929866527666200924144908.

[48] Ichzan, A.M., Hwang, S.H., Cho, H., Fang, C.S., Park, S., Kim, G., Kim, J., Nandhakumar, P., Yu, B., Jon, S., Kim, K.S.*, Yang, H.* (2021) Solid-Phase Recombinase Polymerase Amplification Using an Extremely Low Concentration of a Solution Primer for Sensitive Electrochemical Detection of Hepatitis B Viral DNA. Biosens. Bioelectron. 179: 113065; DOI: 10.1016/j.bios.2021.113065

[47] Cho, H.+, Naskar, A.+, Lee, S., Kim, S., Kim, K.S.* (2021) A new surface charge neutralizing nano-adjuvant to potentiate polymyxins in killing Mcr-1 mediated drug-resistant Escherichia coliPharmaceutics. 13: 250 (+equal contribution); DOI:10.3390/pharmaceutics13020250.

[46] Naskar, A.,  Kim, K.S.* (2021)  Potential novel food-related and biomedical applications of nanomaterials combined with bacteriocins. Pharmaceutics. 13: 86;  DOI: 10.3390/pharmaceutics13010086;

https://encyclopedia.pub/7591

[45] Naskar, A.+, Lee, S.+, Kim, K.S.* (2021) Au–ZnO conjugated black phosphorus as a near-infrared light-triggering and recurrence-suppressing nanoantibiotic platform against Staphylococcus aureus. Pharmaceutics. 13: 52 (+equal contribution); DOI: 10.3390/pharmaceutics13010052.

​[Year 2020]

[44] Cho, H., Jung, Y.H., Cho, H.B., Kim, H.-t.*, Kim, K.S.* (2020) Positive control synthesis method for COVID-19 diagnosis by one-step real-time RT-PCR. Clin. Chim. Acta 511: 149-153; DOI: 10.1016/j.cca.2020.10.001.

 

[43] Naskar, A.+, Lee, S.+, Lee, Y., Kim, S., Kim, K.S.* (2020) A new nano-platform of erythromycin combined with Ag nano-particle ZnO nano-structure against methicillin-resistant Staphylococcus aureus. Pharmaceutics 12: 841 (+equal contribution); DOI: 10.3390/pharmaceutics12090841.

 

[42] Naskar, A., Kim, K.S.* (2020) Recent advances in nanomaterial-based wound-healing therapeutics. Pharmaceutics 12: 499; DOI: 10.3390/pharmaceutics12060499.

 

[41] Naskar, A., Kim, S., Kim, K.S.* (2020) A nontoxic biocompatible nanocomposite comprising black phosphorus with Au-ɣ-Fe2O3 nanomaterials. RSC Adv. 10: 16162-16167; DOI: 10.1039/D0RA02476G.

[40] Naskar, A.+, Lee, S.+, Kim, K.S.* (2020) Easy one-pot low-temperature synthesized Ag-ZnO nanoparticles and their activity against clinical isolates of methicillin-resistant Staphylococcus aureus. Front. Bioeng. Biotechnol. 8: 216(+equal contribution); DOI: 10.3389/fbioe.2020.00216.

 

[39] Cho, H., Lee, W.H., Kim, Y.K., Kim, K.S.* (2020) Extracellular vesicle-associated antigens as a new vaccine platform against scrub typhus. Biochem. Biophys. Res. Comm. 523: 602-607; DOI: 10.1016/j.bbrc.2020.01.014.

 

[38] Naskar, A+., Lee, S.+, Kim, K.S.* (2020) Antibacterial potential of Ni-doped zinc oxide nanostructure: Comparatively more effective against Gram-negative bacteria including multi-drug resistant strains. RSC Adv. 10: 1232-1242(+equal contribution); DOI: 10.1039/C9RA09512H.

 

​[Year 2019]

[37] Naskar, A., Kim, K.S.* (2019) Black phosphorus nanomaterials as multi-potent and emerging platforms against bacterial infections. Microb. Pathog. 137: 103800; DOI: 10.1016/j.micpath.2019.103800.

[36] Naskar, A., Kim, K.S.* (2019) Nanomaterials as delivery vehicles and components of new strategies to combat bacterial infections: advantages and limitations. Microorganisms 7: 356; DOI: 10.3390/microorganisms7090356.

[35] Shin, J.H., Magar, K.S., Lee, J.W., Kim, K.S.*, Lee, Y.R.* (2019) Design, synthesis, and discovery of novel oxindoles bearing 3-heterocycles as species-specific and combinatorial agents in eradicating Staphylococcus species. Sci. Rep. 9: 8012; DOI: 10.1038/s41598-019-44304-1.

[34] Kim, K.S.* (2019) Current challenges in the development of vaccines and drugs against emerging vector-borne diesases. Curr. Med. Chem. 26: 2974-2986; DOI: 10.2174/0929867325666181105121146.

[33] Ichzan, A.M., Lee, S., Fang, C.S., Nandhakumar, P., Ha, H., Joo, J.M., Kim, K.S.*, Yang, H.* (2019) Use of a Phosphatase-Like DT-Diaphorase Label for the Detection of Outer Membrane Vesicles. Anal. Chem. 91: 4680-4686; DOI: 10.1021/acs.analchem.9b00064.

​[Year 2018]

[32] Cho, H., Kim, K.S.* (2018) Escherichia coli OxyS RNA triggers cephalothin resistance by modulating the expression of CRP-associated genes. Biochem. Biophys. Res. Comm. 506: 66-72; DOI: 10.1016/j.bbrc.2018.10.084.

 

[31] Shin, J., Cho, H., Kim, S., Kim, K.S.* (2018) Role of acid responsive genes in the susceptibility of Escherichia coli to ciclopirox. Biochem. Biophys. Res. Comm. 500: 296-301; DOI: 10.1016/j.bbrc.2018.04.063.

 

[30] Fang, C.S., Kim, K.S., Ha, D.T., Kim, M.S., Yang, H.* (2018) Washing-Free Electrochemical Detection of Amplified Double-Stranded DNAs Using a Zinc Finger Protein. Anal. Chem. 90: 4776−4782; DOI: 10.1021/acs.analchem.8b00143.

 

[29] Shin, J.H., Prabhakaran, V., Kim, K.S.* (2018) The multi-faceted potential of plant-derived metabolites as antimicrobial agents against multidrug-resistant pathogens. Microb. Pathog. 116: 209-214; DOI: 10.1016/j.micpath.2018.01.043

 

​[Year 2017]

[28] Choi, H.I., Kim, M., Jeon, J., Han, J.K., Kim, K.S.* (2017) Overexpression of MicA induces production of OmpC-enriched outer membrane vesicles that protect against Salmonella challenge. Biochem. Biophys. Res. Comm. 490: 991-996; DOI: 10.1016/j.bbrc.2017.06.152.

[27] Kim, M., Kim, K.S.* (2017) Stress-responsively modulated ymdAB-clsC operon plays a role in biofilm formation and apramycin susceptibility in Escherichia coli. FEMS Microbiol. Lett. 364: fnx114; DOI: 10.1093/femsle/fnx114.

[26] Fang, C.S., Kim, K.S., Yu, B., Jon, S., Kim, M.S., Yang, H.* (2017) Ultrasensitive electrochemical detection of miRNA-21 using a zinc finger protein specific to DNA-RNA hybrids. Anal. Chem. 89: 2024-2031; DOI: 10.1021/acs.analchem.6b04609.

 

[25] Kim, M., Kim, M., Kim, K.S.* (2017) YmdB-mediated down-regulation of sucA inhibits biofilm formation and induces apramycin susceptibility in Escherichia coli. Biochem. Biophys. Res. Comm. 483: 252-257; DOI: 10.1016/j.bbrc.2016.12.157.

​[Year 2015]

[24] Bak, G., Lee, J., Suk, S., Kim, D., Lee, J.Y., Kim, K.S., Choi, B.S., Lee, Y. (2015) Identification of novel sRNAs involved in biofilm formation, motility, and fimbriae formation in Escherichia coli. Sci. Rep. 5: 15287; DOI: 10.1038/srep15287.

[23] Lee, W.H., Choi, H.I., Hong, S.W., Kim, K.S., Gho, Y.S., Jeon, S.G. (2015) Vaccination with Klebsiella pneumoniae-derived extracellular vesicles protects bacteria-induced lethality via both humoral and cellular immunity. Exp. Mol. Med. 47: e183; DOI: 10.1038/emm.2015.59

 

[22] Kim, T.Y., Bak, G., Lee, J.Y., Kim, K.S.* (2015) Systematic analysis of the role of bacterial Hfq-interacting sRNAs in the response to antibiotics. J. Antimicrob. Chemother. 70: 1659; DOI: 10.1093/jac/dkv042.

 

[21] Bak, G., Hong, S.K., Jung, J.Y.*, Kim, K.S.* (2015) Construction of a yeast three-hybrid system for identifying Escherichia coli proteins interacting with small noncoding RNAs. Bull. Kor. Chem. Soc. 36: 1292; https://doi.org/10.1002/bkcs.10234.

 

[20] Kim, K.S.*, Kim, T., Pan, J.G.* (2015) In vitro evaluation of ciclopirox as an adjuvant for polymyxin B against gram-negative bacteria. J. Antibiot. 68: 395; DOI: 10.1038/ja.2014.164.

 

[19] Bak, G., Han, K., Kim, K.S., Lee. Y. (2015) Electrophoretic mobility shift assay of RNA-RNA complexes. Methods Mol. Biol. 1240: 153-163; DOI: 10.1007/978-1-4939-1896-6_12.

 

​[Year 2013]

[18] Kim, T.Y., Lee, J.Y., Kim, K.S.* (2013) Escherichia coli YmdB regulates biofilm formation independently of its role as an RNase III modulator. BMC Microbiol. 13: 266; DOI: 10.1186/1471-2180-13-266.

 

[17] Lee, J.Y., Park, H., Bak, G., Kim, K.S.*, Lee, Y.* (2013) Regulation of transcription from two ssrS promoters in 6S RNA biogenesis. Mol. Cells. 36: 227-234; DOI: 10.1007/s10059-013-0082-1.

 

[16] Kim, K.S., Lee, S., Ryu, C.M. (2013) Interspecific bacterial sensing through airborne signals modulates locomotion and drug resistance. Nat. Comm. 4: 1809; DOI: 10.1038/ncomms2789.

 

​[Year 2012]

[15] Kim, K.S.*, Park, S., Lee, S., Kang, S., Lee, J., Lee, S.G., Ryu, C.M. (2012) A novel fluorescent reporter system for monitoring and identifying RNase III activity and its target RNAs. RNA Biol. 9: 1167-1176; DOI: 10.4161/rna.21499.

 

[14] Manasherob, R., Miller, C., Kim, K.S., Cohen, S.N. (2012) Ribonuclease E modulation of the bacterial SOS response. PLoS One 7: e38426; DOI: 10.1371/journal.pone.0038426.

 

[13] Shin, J., Kim, K.S., Ryu, K., Han, K., Lee, Y., Choi, B,S. (2012) Structural analysis of Escherichia coli C5 protein. Proteins 80: 963-967; DOI: 10.1002/prot.23253.

 

​[Year 2011]

[12] Han, K., Bak, G., Uhm, K., Kim, K.S.*, Lee, Y.* (2011) Construction of an Efficient In Vitro System for Analysis of Transcription from Sigma 54-Dependent pspA Promoter. Bull. Kor. Chem. Soc. 32: 2129-2131; DOI: 10.1074/jbc.M110.150201.

 

[11] Chae, H., Han, K., Kim, K.S., Park, H., Lee, J.M., and Lee, Y. (2011) Rho-dependent termination of ssrS (6S RNA) transcription in Escherichia coli: implications for 3′ processing of 6S RNA and expression of downstream ygfA. J. Biol. Chem. 286: 114-122; DOI: 10.1074/jbc.M110.150201

 

​[~Year 2010]

[10] Han, K., Kim, K.S., Bak, G., Park, H., Lee, Y. (2010) Recognition and discrimination of target mRNAs by Sib RNAs, a cis-encoded sRNA. Nucl. Acids Res. 38: 5851-5866; DOI: 10.1093/nar/gkq292.

 

[9] Kim, K.S., Manasherob, M., Cohen, S.N. (2008) YmdB: a stress-responsive ribonuclease-binding regulator of E. coli RNase III activity. Genes Dev. 22: 3497-3508; DOI: 10.1101/gad.1729508.

 

[8] Ko, J., Han, K., Kim, Y., Sim, S., Kim, K.S., Lee, S.J., Cho, B., Lee, K., Lee, Y. (2008) Dual function of RNase E for control of M1 RNA biosynthesis in Escherichia coli. Biochemistry 47: 762-770; DOI: 10.1021/bi701528j.

 

[7] Kim, Y., Han, K., Lee, J., Kim, K.S., Lee, Y. (2007) Expression of a small protein encoded by the 3' flanking sequence of the Escherichia coli rnpB gene. Bull. Kor. Chem. Soc. 28: 1010-1014; https://doi.org/10.5012/bkcs.2007.28.6.1010.

[6] Kim, K.S., Ryoo, H., Lee, J.H., Kim, M., Kim, T., Kim, Y., Han, K., Lee, S., Lee, Y. (2006) Selection and Analysis of Genomic Sequence-Derived RNA Motifs Binding to C5 Protein. Bull. Kor. Chem. Soc. 27: 699-704; https://doi.org/10.5012/bkcs.2006.27.5.699.

 

[5] Choi, H., Kim, K.S., Park, J.W., Jung, Y.H., Lee, Y. (2005) Effect of FIS protein on rnpB transcription in E. coli. Mol. Cells. 19: 235-245; PMID: 15879709.

[4] Kim, K.S., Sim, S., Ko, J.H., Lee, Y. (2005) Processing of M1 RNA at the 3' end protects its primary transcript from degradation. J. Biol. Chem. 280: 34667-34674; DOI: 10.1074/jbc.m505005200.

 

[3] Kim, K.S., Sim, S., Ko, J., Cho, B., Lee, Y. (2004) Kinetic analysis of precursor M1 RNA molecules for exploring substrate specificity of the N-terminal catalytic half of RNase E. J. Biochem. 136: 693-699; DOI: 10.1093/jb/mvh176.

 

[2] Kim, K.S., Lee, Y. (2004) Regulation of 6S RNA biogenesis in Escherichia coli: Regulation by switching utilization of both sigma factors and endoribonucleases. Nucl. Acids Res. 32: 6057-6068; DOI: 10.1093/nar/gkh939.

 

[1] Sim, S., Kim, K.S., Lee, Y. (2002) 3'-end processing of precursor M1 RNA by the N-terminal half of RNase E. FEBS Lett. 529: 225-231; DOI: 10.1016/s0014-5793(02)03345-8.

bottom of page